Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Cadila Pharmaceuticals Limited
Location
T. Score
Peers
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

CADILA PHARMACEUTICALS LIMITED

cadilapharma.com

Active

Updated: 23 Oct 2024

The company is engaged in pharmaceutical industry.

Cadila Pharmaceuticals Limited, is an unlisted public company incorporated on 28 February, 1991. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 120.65 cr and the total paid-up capital is INR 80.01 cr.

Industry

Manufacturing of Pharmaceuticals

Products

Formulations, injections., API, tablets

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

0.1%

₹ 2,525.4

EBITDA

112.06%

₹ 202.4

Net Profit

521.68%

₹ 72.2

Networth

17.75%

₹ 1,685.5

Borrowings

39.4%

₹ 1,219.2

Assets

23.09%

₹ 3,943.9

Gross Margin

0.55

61.1 %

Operating Margin

4.23

8.0 %

Net Profit Margin

2.36

2.8 %

Return on Equity

3.47

4.3 %

ROCE

5.48

7.8 %

Debt to Equity

0.11

0.7

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (37)

State	Type	Address

Locations on Map

Tofler Score

Good

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

LOW INTEREST COVERAGE
RECEIVABLES DETERIORATING
LOW ROCE
PAYABLES DETERIORATING

Low Risk

NET MARGIN DETERIORATING

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Peers / Similar Companies

Ajanta Pharma Limited Maharashtra

Pfizer Limited Maharashtra

Emcure Pharmaceuticals Limited Maharashtra

Msn Laboratories Private Limited Telangana

Peers

Ajanta Pharma Limited

Maharashtra

Pfizer Limited

Maharashtra

Emcure Pharmaceuticals Limited

Maharashtra

Msn Laboratories Private Limited

Telangana

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	2,082.2	2,356.9	2,546.2	2,522.8	2,525.4
Operating profit	319.4	442.2	318.9	95.4	202.4
Net profit	164.1	253.2	188.9	11.6	72.2
Gross margin	62.5	61.3	60.1	60.5	61.1
Operating margin	15.3	18.8	12.5	3.8	8.0
Net margin	7.8	10.7	7.3	0.5	2.8
Networth	573.5	822.5	928.2	1,431.4	1,685.5
Borrowings	717.8	492.0	521.9	874.6	1,219.2
Assets	1,939.0	2,018.2	2,275.4	3,203.9	3,943.9
Debt to equity	1.2	0.6	0.6	0.6	0.7
Current ratio	1.0	1.1	1.0	1.0	1.2
ROE	28.6	30.8	20.4	0.8	4.3
Days payable	121.0	121.0	135.0	153.0	199.0
WC days	0.0	14.0	-1.0	-1.0	31.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	80.0	80.0	80.0	80.0	80.0
Reserves	493.5	742.5	848.2	1,351.4	1,605.5
Borrowings +	717.8	492.0	521.9	874.6	1,219.2
Long term borrowings	420.4	305.2	256.2	533.2	844.8
Short term borrowings	297.4	186.8	265.7	341.4	374.4
Trade payables +	258.9	302.8	375.1	417.3	536.6
Days payable	121.0	121.0	135.0	153.0	199.0
Other liabilities +	647.6	703.7	825.3	897.9	1,039.1
Other non-current liabilities	102.9	108.1	117.9	117.7	128.9
Other current liabilities	285.8	292.9	332.2	362.9	373.6
Total liabilities	1,939.0	2,018.2	2,275.4	3,203.9	3,943.9
Fixed Assets +	724.8	727.9	721.3	1,351.6	1,464.8
Tangible assets	705.8	702.2	683.5	1,224.2	1,294.9
CWIP	11.0	16.9	30.7	120.3	157.5
Intangible assets	8.1	8.8	7.2	7.1	12.5
LT loans and advances	-	-	-	-	-
Other non-current assets	369.9	417.7	586.5	739.6	978.1
Current assets +	844.3	872.6	967.6	1,112.8	1,500.9
Inventories	268.3	289.3	333.7	351.0	397.3
Trade receivables	405.9	429.0	452.5	507.8	629.8
Cash and cash equivalents	33.7	25.3	30.6	29.5	222.1
ST loans and advances	-	-	-	-	-
Other current assets	136.4	129.1	150.8	224.5	251.6
Total assets	1,939.0	2,018.2	2,275.4	3,203.9	3,943.9

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	4.13	3.96	3.52	2.5	2.03
Reserves	25.45	36.79	37.28	42.18	40.71
Borrowings +	37.02	24.38	22.94	27.3	30.91
Long term borrowings	21.68	15.12	11.26	16.64	21.42
Short term borrowings	15.34	9.26	11.68	10.66	9.49
Trade payables	13.35	15.0	16.49	13.02	13.61
Other liabilities +	33.4	34.87	36.27	28.03	26.35
Other non-current liabilities	5.31	5.36	5.18	3.67	3.27
Other current liabilities	14.74	14.51	14.6	11.33	9.47
Total liabilities
Fixed Assets +	37.38	36.07	31.7	42.18	37.14
Tangible assets	36.4	34.79	30.04	38.21	32.83
CWIP	0.57	0.84	1.35	3.75	3.99
Intangible assets	0.42	0.44	0.32	0.22	0.32
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	19.08	20.7	25.77	23.08	24.8
Current assets +	43.54	43.24	42.52	34.73	38.06
Inventories	13.84	14.33	14.67	10.96	10.07
Trade receivables	20.93	21.26	19.89	15.85	15.97
Cash and cash equivalents	1.74	1.25	1.34	0.92	5.63
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	7.04	6.39	6.63	7.01	6.38
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	80.0	80.0	80.0	80.0	80.0
Reserves	793.6	1,271.1	1,357.7	1,837.4	2,638.5
Borrowings +	922.7	915.1	921.1	1,452.4	1,826.4
Long term borrowings	604.4	703.8	511.8	909.2	1,161.5
Short term borrowings	318.3	211.2	409.2	543.2	664.9
Trade payables +	288.3	321.6	404.3	463.5	499.0
Days payable	117.0	114.0	112.0	93.0	110.0
Other liabilities +	736.1	799.3	1,103.7	1,199.6	1,331.3
Other non-current liabilities	127.6	141.2	399.2	420.9	424.7
Other current liabilities	320.2	336.5	300.2	315.2	407.6
Total liabilities	2,532.4	3,065.4	3,462.5	4,569.5	5,876.2
Fixed Assets +	1,258.1	1,338.5	1,860.8	2,743.8	3,237.1
Tangible assets	1,026.2	1,107.7	1,551.1	2,247.6	2,659.1
CWIP	217.1	216.0	297.2	483.2	559.8
Intangible assets	14.9	14.8	12.5	13.0	18.1
LT loans and advances	-	-	-	-	-
Other non-current assets	356.6	486.1	484.3	472.7	523.7
Current assets +	917.7	1,240.8	1,117.4	1,353.0	2,115.4
Inventories	302.1	341.7	378.0	385.6	453.8
Trade receivables	401.8	422.4	449.9	496.4	592.7
Cash and cash equivalents	68.1	98.1	133.3	120.5	514.3
ST loans and advances	-	-	-	-	-
Other current assets	145.7	378.7	156.3	350.5	554.6
Total assets	2,532.4	3,065.4	3,462.5	4,569.5	5,876.2

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	3.16	2.61	2.31	1.75	1.36
Reserves	31.34	41.47	39.21	40.21	44.9
Borrowings +	36.43	29.85	26.6	31.79	31.08
Long term borrowings	23.87	22.96	14.78	19.9	19.77
Short term borrowings	12.57	6.89	11.82	11.89	11.32
Trade payables	11.38	10.49	11.68	10.14	8.49
Other liabilities +	29.07	26.07	31.88	26.25	22.66
Other non-current liabilities	5.04	4.61	11.53	9.21	7.23
Other current liabilities	12.64	10.98	8.67	6.9	6.94
Total liabilities
Fixed Assets +	49.68	43.66	53.74	60.05	55.09
Tangible assets	40.52	36.14	44.8	49.19	45.25
CWIP	8.57	7.05	8.58	10.57	9.53
Intangible assets	0.59	0.48	0.36	0.28	0.31
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	14.08	15.86	13.99	10.34	8.91
Current assets +	36.24	40.48	32.27	29.61	36.0
Inventories	11.93	11.15	10.92	8.44	7.72
Trade receivables	15.87	13.78	12.99	10.86	10.09
Cash and cash equivalents	2.69	3.2	3.85	2.64	8.75
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	5.75	12.35	4.51	7.67	9.44
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	2,082.2	2,356.9	2,546.2	2,522.8	2,525.4
Sales growth %	12.81	13.19	8.03	-0.92	0.1
Expenses +	1,900.5	2,025.8	2,327.7	2,553.0	2,506.1
Cost of goods	781.8	912.7	1,016.9	996.2	983.3
Employee cost	382.8	396.6	415.2	525.6	492.2
Other costs	598.2	605.3	795.2	905.6	847.5
Operating profit +	319.4	442.2	318.9	95.4	202.4
Operating margin %	15.3	18.8	12.5	3.8	8.0
Other income	25.3	14.1	41.4	53.3	39.2
Interest	75.9	47.4	35.0	60.8	111.3
Depreciation	61.8	63.7	65.4	64.8	71.8
Exceptional items	-	-	-	-	39.7
Profit before tax	207.0	345.1	259.9	23.1	98.1
Tax	42.9	91.9	71.0	11.5	25.9
Profit - disc. ops	-	-	-	-	-
Net profit	164.1	253.2	188.9	11.6	72.2
Net margin %	7.8	10.7	7.3	0.5	2.8

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	98.8	99.41	98.4	97.93	98.47
Expenses +	90.18	85.44	89.96	99.1	97.72
Cost of goods	37.09	38.5	39.3	38.67	38.34
Employee cost	18.17	16.73	16.04	20.4	19.19
Other costs	28.38	25.53	30.73	35.15	33.05
Operating profit	15.16	18.65	12.32	3.7	7.89
Other income	1.2	0.59	1.6	2.07	1.53
Interest	3.6	2.0	1.35	2.36	4.34
Depreciation	2.93	2.69	2.53	2.52	2.8
Exceptional items	0.0	0.0	0.0	0.0	1.55
Profit before tax	9.82	14.56	10.04	0.9	3.83
Tax	2.03	3.87	2.74	0.45	1.01
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	7.79	10.68	7.3	0.45	2.81

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	2,381.3	2,690.1	3,224.1	3,675.9	3,670.3
Sales growth %	18.74	12.97	19.85	14.01	-0.15
Expenses +	2,133.6	2,282.6	2,884.6	3,740.2	3,579.1
Cost of goods	901.8	1,029.5	1,312.7	1,822.0	1,662.0
Employee cost	418.9	433.0	464.9	604.7	580.7
Other costs	640.6	662.7	942.0	1,100.0	1,017.3
Operating profit +	420.0	564.9	504.5	149.2	410.3
Operating margin %	17.6	21.0	15.7	4.1	11.2
Other income	22.7	16.1	26.2	86.9	40.0
Interest	88.7	67.1	65.7	100.2	158.0
Depreciation	83.7	90.3	99.3	113.3	161.1
Exceptional items	-	-	-	-	7.8
Profit before tax	270.4	423.6	365.7	22.7	138.9
Tax	62.6	106.7	115.0	33.1	45.7
Profit - disc. ops	-0.1	-1.0	-	-	-
Net profit	212.2	318.5	252.8	-10.7	101.0
Net margin %	8.8	11.8	7.8	-0.3	2.7

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	99.06	99.4	99.19	97.69	98.92
Expenses +	88.75	84.35	88.75	99.4	96.46
Cost of goods	37.51	38.04	40.39	48.42	44.79
Employee cost	17.42	16.0	14.3	16.07	15.65
Other costs	26.65	24.49	28.98	29.23	27.42
Operating profit	17.47	20.87	15.52	3.96	11.06
Other income	0.94	0.6	0.81	2.31	1.08
Interest	3.69	2.48	2.02	2.66	4.26
Depreciation	3.48	3.34	3.06	3.01	4.34
Exceptional items	0.0	0.0	0.0	0.0	0.21
Profit before tax	11.25	15.65	11.25	0.6	3.74
Tax	2.6	3.94	3.54	0.88	1.23
Profit - disc. ops	-0.01	-0.04	0.0	0.0	0.0
Net profit	8.83	11.77	7.78	-0.29	2.72

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	1.2	0.6	0.6	0.6	0.7
Net Debt/Equity	1.2	0.6	0.5	0.6	0.6
Total Debt/Assets	0.4	0.2	0.2	0.3	0.3
Total Assets/Equity	3.4	2.5	2.5	2.2	2.3
Liquidity +
Current Ratio	1.0	1.1	1.0	1.0	1.2
Quick Ratio	0.7	0.8	0.7	0.7	0.9
Interest Coverage	4.2	9.3	9.1	1.6	1.8
Performance
Gross Margin	62.5	61.3	60.1	60.5	61.1
Operating Margin	15.3	18.8	12.5	3.8	8.0
Net Margin	7.8	10.7	7.3	0.5	2.8
Return +
Return on Equity	28.6	30.8	20.4	0.8	4.3
Pre-tax ROCE	35.4	46.3	35.4	2.3	7.8
Return on Assets	8.5	12.6	8.3	0.4	1.8
Pre-tax ROIC	20.5	29.4	17.9	1.3	4.9
Efficiency +
Days Payable	121.0	121.0	135.0	153.0	199.0
Days Inventory	125.0	116.0	120.0	129.0	147.0
Days Receivable	71.0	66.0	65.0	73.0	91.0
Fixed Asset Turnover	2.9	3.2	3.5	1.9	1.7
Total Asset Turnover	1.1	1.2	1.1	0.8	0.6
Working Capital
Cash Conversion Cycle	75.0	61.0	50.0	49.0	39.0
Working Capital Days	0.0	14.0	-1.0	-1.0	31.0

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	1.1	0.7	0.6	0.8	0.7
Net Debt/Equity	1.0	0.6	0.6	0.7	0.5
Total Debt/Assets	0.4	0.3	0.3	0.3	0.3
Total Assets/Equity	2.9	2.3	2.4	2.4	2.2
Liquidity +
Current Ratio	1.0	1.4	1.0	1.0	1.4
Quick Ratio	0.7	1.0	0.7	0.7	1.1
Interest Coverage	4.7	8.4	7.7	1.5	2.6
Performance
Gross Margin	62.1	61.7	59.3	50.4	54.7
Operating Margin	17.6	21.0	15.7	4.1	11.2
Net Margin	8.8	11.8	7.8	-0.3	2.7
Return +
Return on Equity	24.3	23.6	17.6	-0.6	3.7
Pre-tax ROCE	26.9	27.8	21.7	1.3	6.6
Return on Assets	8.4	10.4	7.3	-0.2	1.7
Pre-tax ROIC	19.5	21.9	18.2	1.1	6.2
Efficiency +
Days Payable	117.0	114.0	112.0	93.0	110.0
Days Inventory	122.0	121.0	105.0	77.0	100.0
Days Receivable	62.0	57.0	51.0	49.0	59.0
Fixed Asset Turnover	1.9	2.0	1.7	1.3	1.1
Total Asset Turnover	0.9	0.9	0.9	0.8	0.6
Working Capital
Cash Conversion Cycle	67.0	64.0	44.0	33.0	49.0
Working Capital Days	-1.0	50.0	0.0	3.0	54.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

Axis Trustee Services Limited

No. of Loans: 1

Total Amount : 1,569.3 cr

Bank of Baroda

No. of Loans: 3

Total Amount : 825.0 cr

Canara Bank

No. of Loans: 1

Total Amount : 300.0 cr

Bank of Baroda, CFS Branch

No. of Loans: 1

Total Amount : 300.0 cr

Bank of India

No. of Loans: 2

Total Amount : 200.0 cr

Export-Import Bank of India

No. of Loans: 1

Total Amount : 170.0 cr

Axis Bank Limited

No. of Loans: 1

Total Amount : 153.6 cr

HDFC Bank Limited

No. of Loans: 3

Total Amount : 124.2 cr

Corporation Bank

No. of Loans: 1

Total Amount : 75.0 cr

Union Bank of India

No. of Loans: 1

Total Amount : 75.0 cr

Charge Holder	Amount	Date of creation/modification
HDFC Bank Limited	63.8 cr	13 Jun, 2024
Axis Bank Limited	153.6 cr	06 Jun, 2024
Axis Trustee Services Limited	1,569.3 cr	22 Apr, 2024
Canara Bank	300.0 cr	29 Sep, 2023
Bank of India	100.0 cr	23 Jun, 2023
Bank of Baroda, CFS Branch	300.0 cr	17 Mar, 2023
Export-Import Bank of India	170.0 cr	31 Mar, 2022
Bank of India	100.0 cr	02 Nov, 2021
Bank of Baroda	450.0 cr	02 Mar, 2020
Corporation Bank	75.0 cr	27 Dec, 2019
Bank of Baroda	75.0 cr	12 Apr, 2019
Union Bank of India	75.0 cr	09 Apr, 2018
HDFC Bank Limited	60.0 cr	29 Jun, 2017
Bank of Baroda	300.0 cr	09 Mar, 2016
HDFC Bank Limited	0.4 cr	31 Jan, 2008

Charges

Axis Trustee Services Limited

Bank of Baroda

Canara Bank

Bank of Baroda, CFS Branch

Others

People

Designation	Name	DIN/PAN	Tenure
Director	Girdhar Prem Balwani	00328949	8 years
Managing Director	Rajiv Indravadan Modi Shareholder	01394558	34 years
Whole-time Director	Ramesh Ratilal Choksi	06636737	11 years
Kmp	Renuka Anjanikumar Upadhyay	<HIDDEN>	1 years
Director	Abhijat Chandrakant Sheth	07937206	7 years
Director	Parul Nikunj Shah	09314433	1 years
CFO	Kamlesh Navaratnalal Shah	<HIDDEN>	2 years
Director	Rajiv Rajiv Modi	10276899	1 years
Director	Manvantkumar Shankerlal Rami	10404588	1 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
SKANEM INTERLABELS INDUSTRIES NORTH PRIVATE LIMITED	Amalgamated	1.0 L	1	Maharashtra
AQUATAR SECURITIES PRIVATE LIMITED	Strike Off	3.0 L	1	Maharashtra
INOVAIL PHARMACEUTICALS (INDIA) PRIVATE LIMITED	Amalgamated	5.0 L	1	Gujarat
INNOPHARM HEALTHCARE PRIVATE LIMITED	Active	10.0 L	1	Maharashtra
SKANEM INDIA PRIVATE LIMITED	Active	3.6 Cr	1	Maharashtra
APOLLO CVHF LIMITED	Active	15.0 Cr	1	Gujarat
CADILA LABORATORIES PRIVATE LIMITED	Active	3.8 Cr	1	Gujarat
IRM BRANDS PRIVATE LIMITED	Amalgamated	1.5 Cr	1	Gujarat
CASIL INDUSTRIES LIMITED	Amalgamated	15.6 Cr	2	Gujarat
KARNAVATI ENGINEERING PRIVATE LIMITED	Amalgamated	3.0 Cr	2	Gujarat
CADINDIA INSURANCE COMPANY LIMITED	Strike Off	7,000.0	1	Gujarat
CASIL BG MEDICAL DEVICES PRIVATE LIMITED	Strike Off	2.4 Cr	1	Gujarat
CASIL INDUSTRIES LIMITED	Amalgamated	30.6 Cr	2	Gujarat
IRM PROPERTIES PRIVATE LIMITED	Amalgamated	4.6 Cr	1	Gujarat
MEDTEK ASIA PRIVATE LIMITED	Amalgamated	1.6 Cr	1	Gujarat
CPL INFRASTRUCTURE PRIVATE LIMITED	Amalgamated	1.0 L	1	Gujarat
GREEN CHANNEL LOGI-SOLUTIONS LIMITED	Active	5.0 L	2	Gujarat
CASIL HEALTH PRODUCTS LIMITED	Active	4.8 Cr	2	Gujarat
GIG - IRM GLASS INSULATORS PRIVATE LIMITED	Active	9.7 Cr	1	Gujarat
CPL INFRASTRUCTURE PRIVATE LIMITED	Active	59.7 Cr	2	Gujarat
CPL HOLDINGS PRIVATE LIMITED	Active	1.1 Cr	1	Gujarat
LA VIE AGRICARE PRIVATE LIMITED	Active	5.0 L	1	Gujarat
CASIL FINANCE PRIVATE LIMITED	Strike Off	4,000.0	1	Gujarat
APOLLO HOSPITALS INTERNATIONAL LIMITED	Active	100.6 Cr	2	Tamil Nadu
IRM ENTERPRISES PRIVATE LIMITED	Active	10.0 L	4	Gujarat
CPL HOLDINGS LLP	Active	1.1 Cr	1	Gujarat
IRM PRIVATE LIMITED	Active	11.2 Cr	2	Gujarat
IRM ENERGY LIMITED	Active	76.1 Cr	1	Gujarat
CPL BIOLOGICALS PRIVATE LIMITED	Active	45.3 Cr	3	Gujarat
INVERIKA BIORESEARCH PRIVATE LIMITED	Active	8.2 Cr	1	Gujarat
CAD VENTURES PRIVATE LIMITED	Active	4.0 Cr	1	Gujarat
CPL PHARMACEUTICALS PRIVATE LIMITED	Active	80.3 Cr	2	Gujarat
RENASCENCE HEALTHCARE PRIVATE LIMITED	Not available for efiling	1.0 L	1	Gujarat

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
CPL BIOLOGICALS PRIVATE LIMITED	Gujarat	2009	₹ 45.3 Cr
Satellite Overseas (Holdings) Ltd.	Isle Of Man	-	-
IRM ENERGY LIMITED	Gujarat	2015	₹ 76.1 Cr
Cadila Pharmaceuticals (Ethiopia) Plc.	Ethiopia	-	-
SOHL Inc.	United States	-	-
Cadila Pharmaceuticals (EA) Ltd.	Kenya	-	-
Kadera Yakuhin Ltd.	Japan	-	-
Cadila Pharmaceuticals (Europe) Ltd.	United Kingdom	-	-
OOO Cadila Pharmaceuticals (Russia) Ltd.	Russian Federation	-	-
Modavar Pharmaceutical LLC.	United States	-	-
RRM Properties LLC.	United States	-	-
Interpharma Industries Ltd.	Nigeria	-	-
CPL Biologicals US.LLC	United States	-	-
RISM Ltd.	Isle Of Man	-	-
Cadila Pharmaceuticals (Uzbekistan) LLC	Uzbekistan	-	-
CPL PHARMACEUTICALS PRIVATE LIMITED	Gujarat	2021	₹ 80.3 Cr
MARTAND AVIATION GLOBAL HOLDINGS LTD	Ireland	-	-
CPL Overseas Trading FZE	United Arab Emirates	-	-

Registered Details

CIN

U24231GJ1991PLC015132

PAN

AAACC6251E

Incorporation

1991, 34.1 years

Company Email

secretarial@cadilapharma.co.in

Paid up Capital

₹ 80.0 Cr

Authorised Capital

₹ 120.7 Cr

AGM

Aug 2023

Type

Public

Non-government Company

FAQ - CADILA PHARMACEUTICALS LIMITED

What is the incorporation date of CADILA PHARMACEUTICALS LIMITED?

The incorporation date of CADILA PHARMACEUTICALS LIMITED is 28 February, 1991

What is the authorized share capital of CADILA PHARMACEUTICALS LIMITED?

The authorized share capital of CADILA PHARMACEUTICALS LIMITED is INR ₹ 120.7 Cr.

What is the paid-up capital of CADILA PHARMACEUTICALS LIMITED?

The paid-up capital of CADILA PHARMACEUTICALS LIMITED is INR ₹ 80.0 Cr.

What is the registered address of CADILA PHARMACEUTICALS LIMITED?

The registered address of CADILA PHARMACEUTICALS LIMITED is CADILA CORPORATE CAMPUS SARKHEJ DHOLKA ROAD,BHAT AHMEDABAD Gujarat - 382210

What is the CIN number of CADILA PHARMACEUTICALS LIMITED?

The CIN number of CADILA PHARMACEUTICALS LIMITED is U24231GJ1991PLC015132.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

CADILA PHARMACEUTICALS LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Peers / Similar Companies

Peers

Ajanta Pharma Limited

Pfizer Limited

Emcure Pharmaceuticals Limited

Msn Laboratories Private Limited

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network